Cardiff Oncology Drops 34% After CEO and CFO Resign
Cardiff Oncology shares fall sharply as CEO and CFO step down amid leadership transition; interim CEO appointed to guide next phase of drug development.
/ 904 items
#Healthcare↓
Intellia Shares Jump After FDA Lifts Clinical Hold on Gene Therapy Trial
Intellia Therapeutics’ stock rises as the FDA clears a Phase 3 trial for its gene therapy, nexiguran ziclumeran, for a rare genetic disease.
HCA Healthcare Beats Expectations, Shares Jump on Strong Outlook
HCA Healthcare reported strong quarterly earnings and forecast higher-than-expected profits for 2026, driven by steady patient demand and government-backed insurance plans.
UnitedHealth Reports First Revenue Decline in 37 Years Amid Major Restructuring
UnitedHealth forecasts its first annual revenue decline since 1989, projecting 2026 revenues above $439 billion as the health care giant restructures operations and sheds assets to rebuild profitability.
Piper Sandler Starts Coverage on BioAge Labs With Buy Rating and $73 Target
Piper Sandler initiates coverage of BioAge Labs with an Overweight rating, highlighting strong early data for its lead drug BGE-102 and key upcoming catalysts.
Trump Administration Proposes Near-Flat Medicare Advantage Rates, Disappointing Insurers
Trump's CMS proposes minimal 0.09% Medicare payment increase for 2027, far below Wall Street's 4-6% expectations, while eliminating controversial billing practices.